Our very first customer success case study is now available! 🤩 “Limiting dilution involves subjective judgment, which can be difficult to document comprehensively,” remarked Dr. Suzanne Snellenberg. Not with UP.SIGHT. 💡 Using CYTENA's flagship single-cell dispenser and plate imager, Cellistic has achieved high iPSC recovery rates (>50%), reduced errors and labor-intensive work in cell sorting, improved data traceability, streamlined the cloning process, and thus saved time and resources for future lab research. The impact UP.SIGHT has made in Cellistic's lab:  ✨ 90% gene editing efficiency ✨ >50% recovery from single iPSCs Read the full case study to see how you can boost gene editing efficiency and monoclonality in iPSCs, just like Cellistic did! 📖👇 https://lnkd.in/dWzKjvu6 📣 Stay tuned for more customer success stories to come... https://lnkd.in/dzpGCktN #CellTherapy #iPSC #GeneEditing #Biotech #Innovation #SuccessCaseStudy #Automation #UPSIGHT #SingleCellDispenser #PlateImager

✨ Meet #Sally from Pharmabotix AG 🤖 🔬 Still doing all your lab work manually? 👐 🚀 It's time for Sally: Your robotic solution for cell and gene therapy manufacturing and laboratoty applications 🦾 ✅ Handling of cell stacks and culture bottles ✅ Inoculum preparation  ✅ Cell detachment ✅ Handling and accurate filling of cryovials 📽 Witness what an impressive laboratory study it is by watching the video #pharmabotix #robotics #sally #laboratory #handling #preparation #filling #detachment #innovation 👉 Follow me Levent Coskun to stay up to date on #robotics #AI #hightech and #innovation. To get notifications about my posts please activate the notification bell 🔔 in my profile

🚀 Exciting Announcement! 🚀 Introducing a game-changing method now available on the Biomek NGeniuS system! This cutting-edge technology automates library preparation for the Pillar Biosciences oncoReveal™ Solid Tumor 22 Gene Panel, revolutionizing NGS workflows. Highlights: 🧬 Automated library prep for solid tumor samples, including both genomic and FFPE DNA. ⏱️ Streamlines labor-intensive manual steps, enhancing efficiency and reducing errors. 📊 Delivers high-quality sequencing data with Q30 scores >97% and on-target rates >92%. 💡 Ensures reproducible results with accurate variant detection and zero false positives/negatives. This innovation promises to revolutionize your lab's workflow, enabling consistent and high-quality results with minimal operator input. Explore how the Biomek NGeniuS system can transform your sequencing processes! #NGS #Automation #Biotech #Innovation #LabEfficiency

Finally, Pillar kit automated on Biomek NGeniuS !!

🔬 Big news in the BioTech world! Metagenomi and Moderna's collaboration on gene editing technologies has come to an end 🧬 After a 3-year alliance, both companies parted amicably, with Metagenomi regaining full rights to their pioneering base editors and RNA-mediated systems. Although their stock took a hit, dropping 20%, this shift opens new doors for Metagenomi to steer their tech destiny 💡 For us in the MedTech and HealthTech sectors, this means watching a nimble, innovative player take the reins independently. Thoughts on how this will shape the gene editing landscape? #GeneEditing #Biotech #Innovation

🎥 SPOTLIGHT CLIP: The burgeoning field of 𝐂𝐞𝐥𝐥 𝐚𝐧𝐝 𝐆𝐞𝐧𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 (CGT) has often been called “𝐭𝐡𝐞 𝐧𝐞𝐱𝐭 𝐠𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞,” with massive clinical potential. 💉 💊 However, the industry has faced a variety of challenges, from awareness and funding to obstacles in #CGT #manufacturing processes. We’re spotlighting Autolomous and its software program, 𝗔𝘂𝘁𝗼𝗹𝗼𝗠𝗔𝗧𝗘®, which helps CGT manufacturers to integrate information, scale, and streamline operations to lower costs. The #technology provides support from development and clinical trials, toward commercialization. The goal is to expand the reach of 𝐂𝐆𝐓 𝐭𝐡𝐞𝐫𝐚𝐩𝐢𝐞𝐬 to more patients. ⚕️ 🌎 “𝘼𝙪𝙩𝙤𝙡𝙤𝙈𝘼𝙏𝙀® 𝙚𝙣𝙖𝙗𝙡𝙚𝙨 𝙩𝙝𝙚 𝙨𝙝𝙖𝙧𝙞𝙣𝙜 𝙤𝙛 𝙞𝙣𝙛𝙤𝙧𝙢𝙖𝙩𝙞𝙤𝙣 𝙩𝙤 𝙝𝙚𝙡𝙥 𝙨𝙩𝙖𝙣𝙙𝙖𝙧𝙙𝙞𝙯𝙚 𝙥𝙧𝙤𝙘𝙚𝙨𝙨𝙚𝙨. 𝙒𝙚 𝙘𝙖𝙣 𝙩𝙚𝙡𝙡 𝙬𝙝𝙖𝙩’𝙨 𝙝𝙖𝙥𝙥𝙚𝙣𝙞𝙣𝙜 𝙞𝙣 𝙧𝙚𝙖𝙡 𝙩𝙞𝙢𝙚 𝙩𝙤 𝙝𝙚𝙡𝙥 𝙢𝙞𝙩𝙞𝙜𝙖𝙩𝙚 𝙥𝙧𝙤𝙙𝙪𝙘𝙩𝙞𝙤𝙣 𝙘𝙝𝙖𝙡𝙡𝙚𝙣𝙜𝙚𝙨, 𝙖𝙨 𝙬𝙚𝙡𝙡 𝙖𝙨 𝙥𝙧𝙚𝙫𝙚𝙣𝙩 𝙚𝙦𝙪𝙞𝙥𝙢𝙚𝙣𝙩 𝙢𝙖𝙡𝙛𝙪𝙣𝙘𝙩𝙞𝙤𝙣𝙨 𝙖𝙝𝙚𝙖𝙙 𝙤𝙛 𝙩𝙞𝙢𝙚.” Watch short snippets from our segment with CEO Alexander Seyf; Chief Technology Officer Alexis Blain; Head of Product Management Alexa Crăciunescu; Head of Global Cell & Gene Therapy at ‪SK pharmteco,‬ John Lee; and Tom Whitehead, Co-Founder of ‪Emily Whitehead Foundation, which aims to improve #cancer treatment options for children. #biotechnology #research #DigitalTransformation #software #automation #compliance #science #medicine 🎬 𝗗𝗠𝗚 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻𝘀 | ‪Alliance for Regenerative Medicine‬

Is time of the essence? The clocks are ticking louder for scientists and engineers researching new treatments for cancer, genetic disorders, and the pandemics of tomorrow. Moving quickly from discovering to delivering biological therapeutics can make or break its success. Sartorius’ single-use technologies are a speed boost, cutting production time and costs, while enhancing flexibility. This empowers research teams around the world to simplify and accelerate progress in life science and bioprocessing. We’re in this together. Expedite your drug to market through rapid deployment of single-use solutions. Discover our scalable single-use technologies at www.sartorius.com #SimplifyingProgress #LifeSciences #bioprocessing #InThisTogether

Traditionally, cell therapy has been a slow, expensive process, and due to the personalized nature of these therapies, they are difficult to manufacture at scale. This week, at GenScript's 4th Annual Gene and Cell Engineering Summit, our co-founder and CEO Fred (Federico) Parietti shared how we’re addressing this challenge head-on with automation and robotics, offering cell manufacturers: ➡️Compatibility: Automate existing GMP instruments used widely for cell therapy manufacturing today to avoid substantially changing existing processes ➡️Flexibility: Select, remove, add, and swap any combination of modules to automate a wide range of existing processes ➡️Future-proofing: Grow with the industry – the robotic cluster has a modular design that can adjust to accommodate new instruments and technologies as they become available ➡️Cost-efficiency: Achieve higher throughput and utilization by using multiple modules in parallel Thank you to our partner, GenScript, for providing a space to discuss the latest life-saving innovations in cell and gene therapies! #celltherapy #automation #pharma #GCESummit #robotics

Overcome scale-up hurdles for oncolytic herpes simplex virus type-1 vector manufacturing! 💡 Advancements in oncolytic virotherapy are paving the way for groundbreaking treatments across various diseases. However, large-scale manufacturing of viral vectors present challenges in scaling-up, footprint, and COGs. In this study, OBiO Tech leverages Univercells Technologies' scale-X™ fixed-bed bioreactors to achieve consistency in critical quality attributes while scaling up. Discover how OBIO Tech achieved reduction in manpower, material and space, while preserving the high yield maintained across scales for herpes simplex virus type-1 production! 👉 https://lnkd.in/gbZG_2PG #Biomanufacturing #Innovation #viralvectors

Delivering on a 🌈 promise: Use knowledge graphs to have an immediate impact on your early-phase #drugdiscovery decisions? "No way!?" you might think. The correct answer is: "Yes, of course," says knowing01. The magic solution to make it happen: The #Multiomics #AI #software solution from us. I am really excited to see it increasingly adopted by today's #biotech #innovators. Wanna know how? If( time Jul.16, 5pm CEST/ 11am EDT ) { 1️⃣ Attend our https://lnkd.in/dpGvCU6r } else { 2️⃣ Talk to me Nikola or Karolina } #diseaseresearch #singlecell #proteomics #transcriptomics #RNA #protein #RWD #epigenetics #autoimmune #oncology #knowledgegraph